SMARCA4型
生物
染色质
瑞士/瑞士法郎
染色质重塑
染色质结构重塑复合物
ATP酶
蛋白质亚单位
基因
细胞生物学
乙酰化
转录因子
遗传学
生物化学
酶
作者
Joshua Pan,Zachary M. McKenzie,Andrew R. D’Avino,Nazar Mashtalir,Caleb A. Lareau,Roodolph St. Pierre,Lu Wang,Ali Shilatifard,Cigall Kadoch
出处
期刊:Nature Genetics
[Springer Nature]
日期:2019-03-11
卷期号:51 (4): 618-626
被引量:83
标识
DOI:10.1038/s41588-019-0363-5
摘要
Perturbations to mammalian switch/sucrose non-fermentable (mSWI/SNF) chromatin remodeling complexes have been widely implicated as driving events in cancer1. One such perturbation is the dual loss of the SMARCA4 and SMARCA2 ATPase subunits in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)2-5, SMARCA4-deficient thoracic sarcomas6 and dedifferentiated endometrial carcinomas7. However, the consequences of dual ATPase subunit loss on mSWI/SNF complex subunit composition, chromatin targeting, DNA accessibility and gene expression remain unknown. Here we identify an ATPase module of subunits that is required for functional specification of the Brahma-related gene-associated factor (BAF) and polybromo-associated BAF (PBAF) mSWI/SNF family subcomplexes. Using SMARCA4/2 ATPase mutant variants, we define the catalytic activity-dependent and catalytic activity-independent contributions of the ATPase module to the targeting of BAF and PBAF complexes on chromatin genome-wide. Finally, by linking distinct mSWI/SNF complex target sites to tumor-suppressive gene expression programs, we clarify the transcriptional consequences of SMARCA4/2 dual loss in SCCOHT.
科研通智能强力驱动
Strongly Powered by AbleSci AI